Dr Thorsten Giesecke, general manager, commercial business at Janssen Sciences Ireland UC and Irish Pharmaceutical Industry Association (IPHA) strategy board member, outlined in The Irish Times how clinical trials play a critical role in addressing the unmet need in the treatment of the blood cancer, multiple myeloma, and bring us closer to the goal of a future without disease.
You can read the article HERE
CP-395854 | August 2023